Physician profile
Arthur Ting
NPI 1346268620
$26,422.95
in general payments reported to CMS, 2019-2025
12 companies · $10K in 2025
The $10K reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.91 · 2020: $3,278 · 2022: $180 · 2023: $126 · 2024: $13K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $23K · Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $22,613.60 |
| Food and Beverage | $336.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| International Rehabilitative Sciences, INC | $22,706.34 | 2024-2025 | Rs 4i Plus Sequential Stimulator, Rs-Lbg, Rs-Fbg |
| Intravu INC. | $3,277.56 | 2020 | |
| Anika Therapeutics, INC. | $133.33 | 2022 | |
| Ethicon US, LLC | $77.51 | 2023 | Stratafix, Megadyne |
| Depuy Synthes Sales INC. | $41.41 | 2024 | Fms Duo, N/A, Vapr |
| Smith+Nephew, INC. | $31.67 | 2024 | Real Intelligence |
| Electronic Waveform Lab, INC. | $31.55 | 2022-2024 | |
| Evolution Surgical, INC | $29.92 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $29.50 | 2025 | |
| Fidia Pharma USA INC. | $27.12 | 2023 | Hymovis, Triluron |
| Orthofix Medical, INC. | $21.13 | 2023 | Physio-Stim |
| Arthrosurface Incorporated | $15.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,500.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Ting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.